Get the SPI Wire

Pelthos Therapeutics Inc.

NYSE:PTHS
Annual Meeting

of Shareholders

MEETING DATE

09/29/2026
DEF 14A FILED
08/18/2026
PUBLISHED
08/18/2026 9:00 pm
TIME TO PUBLISH
08/20/2026
METHODOLOGY
approve
EXCHANGE NYSE:PTHS · CUSIP 171126204 · CLASS common stock, par value $0.0001 per share and Series A Preferred Stock · CIK 0001919246

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

3
FOR
0
AGAINST
0
WITHHOLD
3
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1
Election of 8 Directors
board
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Filing states none of the directors are involved in certain legal proceedings.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
2
Ratification of Appointment of Independent Registered Public Accountants
auditor
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Filing states there were no disagreements or reportable events with CBIZ.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
3
Approval of the Pelthos Therapeutics Inc. 2026 Equity Incentive Plan
compensation
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Filing states insufficient shares remain under the 2023 Plan for upcoming annual awards.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

2028e59a43ffc0dcdf806470e806f0100c74ccf3233b85254f7cfaa761d85e98

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates